Myrexis Inc Cmn Stk
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
Myrexis Inc Cmn Stk (MYRX) - Total Assets
Latest total assets as of June 2013: $1.24 Million USD
Based on the latest financial reports, Myrexis Inc Cmn Stk (MYRX) holds total assets worth $1.24 Million USD as of June 2013.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Myrexis Inc Cmn Stk - Total Assets Trend (2008–2013)
This chart illustrates how Myrexis Inc Cmn Stk’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Myrexis Inc Cmn Stk - Asset Composition Analysis
Current Asset Composition (June 2013)
Myrexis Inc Cmn Stk's total assets of $1.24 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 91.8% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2013)
This chart illustrates how Myrexis Inc Cmn Stk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Myrexis Inc Cmn Stk's current assets represent 100.0% of total assets in 2013, an increase from 32.9% in 2008.
- Cash Position: Cash and equivalents constituted 91.8% of total assets in 2013, up from 0.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Myrexis Inc Cmn Stk Competitors by Total Assets
Key competitors of Myrexis Inc Cmn Stk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Myrexis Inc Cmn Stk - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Myrexis Inc Cmn Stk generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Myrexis Inc Cmn Stk is currently not profitable relative to its asset base.
Myrexis Inc Cmn Stk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 16.72 | 39.29 | 0.11 |
| Quick Ratio | 16.72 | 39.29 | 0.11 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.16 Million | $ 87.27 Million | $ -41.39 Million |
Myrexis Inc Cmn Stk - Advanced Valuation Insights
This section examines the relationship between Myrexis Inc Cmn Stk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.42 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -98.7% |
| Total Assets | $1.24 Million |
| Market Capitalization | $69.51 USD |
Valuation Analysis
Below Book Valuation: The market values Myrexis Inc Cmn Stk's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Myrexis Inc Cmn Stk's assets decreased by 98.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Myrexis Inc Cmn Stk (2008–2013)
The table below shows the annual total assets of Myrexis Inc Cmn Stk from 2008 to 2013.
| Year | Total Assets | Change |
|---|---|---|
| 2013-06-30 | $1.24 Million | -98.65% |
| 2012-06-30 | $91.65 Million | -24.42% |
| 2011-06-30 | $121.26 Million | -21.31% |
| 2010-06-30 | $154.11 Million | -20.43% |
| 2009-06-30 | $193.68 Million | +1130.01% |
| 2008-06-30 | $15.75 Million | -- |